Avego Management

PBS Biotech specializes in the manufacture of single-use bioreactor systems designed to create homogeneous and scalable mixing conditions for various cell therapy products and cell culture applications. The company offers innovative disposable vessels and bags, alongside process development services that include cell therapy optimization, characterization, and risk analysis. By providing efficient and cost-effective solutions, PBS Biotech enables biotechnology firms to enhance operational efficiency, reduce costs, and effectively address their cell therapy requirements. Their bioreactors are notable for having the smallest per liter volume footprints, making them fully scalable for all stages of the cell culture process, from research and development to clinical and cGMP production. Through their technical expertise and commitment to solving complex cell culture challenges, PBS Biotech supports its clients in achieving their manufacturing goals.

AtomVie Global Radiopharma is a global Contract Development and Manufacturing Organization specializing in radiotherapeutics. The company supports partners throughout the entire process, from early clinical development to commercial manufacturing. AtomVie provides a comprehensive suite of services, including scientific, technical, regulatory, quality, and logistics expertise, ensuring a reliable clinical supply chain. Its specialized infrastructure is designed to facilitate the progression of radiopharmaceuticals from Phase 1 trials to the commercial marketplace, ultimately delivering high-quality drugs for the treatment and diagnosis of various diseases.

PBS Biotech specializes in the manufacture of single-use bioreactor systems designed to create homogeneous and scalable mixing conditions for various cell therapy products and cell culture applications. The company offers innovative disposable vessels and bags, alongside process development services that include cell therapy optimization, characterization, and risk analysis. By providing efficient and cost-effective solutions, PBS Biotech enables biotechnology firms to enhance operational efficiency, reduce costs, and effectively address their cell therapy requirements. Their bioreactors are notable for having the smallest per liter volume footprints, making them fully scalable for all stages of the cell culture process, from research and development to clinical and cGMP production. Through their technical expertise and commitment to solving complex cell culture challenges, PBS Biotech supports its clients in achieving their manufacturing goals.

Escient Pharmaceuticals, Inc. is a biotechnology company based in San Diego, California, specializing in the development and manufacture of G protein-coupled receptor (GPCR)-targeted drugs aimed at treating neuro-immuno-inflammatory and autoreactive diseases. Founded in 2017, Escient focuses on harnessing the therapeutic potential of specific orphan GPCRs, particularly the Mas-Related G-Protein Receptors (Mrgprs). The company aims to provide innovative therapies for a variety of conditions, including mast cell-mediated disorders and cholestatic pruritus, thereby expanding treatment options for healthcare providers facing these complex diseases.

AtomVie Global Radiopharma is a global Contract Development and Manufacturing Organization specializing in radiotherapeutics. The company supports partners throughout the entire process, from early clinical development to commercial manufacturing. AtomVie provides a comprehensive suite of services, including scientific, technical, regulatory, quality, and logistics expertise, ensuring a reliable clinical supply chain. Its specialized infrastructure is designed to facilitate the progression of radiopharmaceuticals from Phase 1 trials to the commercial marketplace, ultimately delivering high-quality drugs for the treatment and diagnosis of various diseases.